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Getting closer to the patient: Upgrade of hepatitis C virus infection in primary human
In recent years, tremendous progress has been made in deciphering HCV-host cell interactions. The establishment of novel and robust infectious model systems has allowed a detailed study of the entire HCV lifecycle in vitro [1] . However, these model systems rely on unique HCV isolates (i. e. JHF1) and on specific cell lines (i. e. Huh7) for a reproducible and standardized analysis of HCV-host cell interactions. In vivo, the hepatocyte is the primary target cell of HCV. The liver architecture is elaborated and hepatocytes are characterized by a complex and highly-polarized morphology [2] . Human hepatoma cells differ from primary human hepatocytes (PHH) with respect to morphology, proliferation, gene expression and innate immune responses but are widely used as surrogate model for human hepatocytes because PHH are difficult to maintain in cell culture and infection with recombinant or serumderived HCV is not robust. Indeed, PHH do not proliferate and tend to rapidly loose their phenotype and viability upon isolation. Therefore, innovative strategies allowing to circumvent these drawbacks and to improve PHH culture are needed. Furthermore, a PHHbased HCV infectious model system would be of great interest to determine the efficacy and toxicity of novel antivirals. Interestingly, transgenic immunodeficient mice with hepatocytelethal phenotype have been successfully transplanted with PHH and are susceptible to HCV infection [3, 4] . In the transplanted mice, PHH may occupy the majority of the liver parenchyma and preserve their phenotype for several months, suggesting that the in vivo microenvironment stabilizes the PHH phenotype.
In the past years, tissue engineering has greatly improved PHH culture conditions in order to preserve and modulate PHH phenotype. Micropatterned coculture (MPCC) of PHH with mouse fibroblasts (3T3-J2 cells) (Figure 1 ) allows stabilizing the PHH phenotype (e. g. synthesis of albumin, urea and cytochrome P450 activity) for several weeks and has been proposed as a model to study drug safety [5] . This model appears robust as stabilization of liver functions was observed with both fresh and cryopreserved PHH from different donors.
Of note, like in monoculture, PHH do not seem to proliferate under MPCC culture conditions.
On the other hand, virologists have been continuously trying to improve the HCV models and most recently two highly sensitive new reporter models were described [6] : Combining these two advancements the Rice laboratory established a new model system to study persistent HCV infection in PHH [7] . Interestingly, MPCC PHH appear to polarize [7] and HCV host entry factor distribution seems to be comparable to liver hepatocytes [8] . Thus, MPCC PHH appear to reflect hepatocyte morphology in the liver more closely than PHH monoculture or hepatoma cells. Noteworthy, MPCC PHH were able to replicate HCV for two weeks as shown by luciferase secretion that was reduced in the presence of HCV polymerase and protease inhibitors [7] . In addition, expression of the fluorescent reporter RFP-NLS-IPS allowed assessment of replication of cell culture and serum-derived HCV at a single cell level. Importantly, in line with previous results obtained in hepatoma cells, antibodies directed against CD81 and HCV E2 inhibited HCV infection. Of note, MPCC PHH are able to support the entire HCV lifecycle as supernatants from infected MPCC PHH were infectious in hepatoma cells [7] . Although HCV infection and viral spread occurred only in a small fraction of cells, MPCC PHH appear to be a valuable and robust model system to study HCV infection in primary cells.
The possibility to use fluorescent reporter proteins in MPCC PHH broadens the scope of this model system as it will allow to study HCV infection of a large panel of genotypes and isolates without engineering reporter viruses. Moreover, as HCV associates with lipoproteins in vivo and this impacts viral entry and neutralization [9, 10] , it will be of interest to compare infectious virions released from MPCC and hepatoma cells with respect to biochemical properties, host factor usage, infectivity and neutralization. Furthermore, this model also offers a unique opportunity to assess the efficacy of novel antivirals but also to determine drug interactions and toxicity in HCV-infected cells [7] .
In conclusion, this original model system based on the natural host cell of HCV infection clearly provides an important step forward for the understanding of virus-host interactions in the HCV-infected liver. 
Reporter virus Reporter cell
